I-MOVE+: Integrated Monitoring of Vaccines in Europe
Its goal is to develop a sustainable platform of primary care, hospital and laboratory networks that use validated standardised methods to evaluate existing and new vaccines programmes independently from commercial interests.
Identify, pilot test, use, and disseminate the best study designs to measure, in near real time the effectiveness and impact of vaccines used in the elderly population to prevent influenza and pneumococcal infections.
I-MOVE+ (Integrated Monitoring of Vaccines in Europe) is a consortium of 26 partners (regional and national public health Institutes, SME, Universities frrom of 15 European Union / European Economic Area Member States.
I-MOVE+ has received a grant (May 2015- Oct 2018) from the European Commission (H2020).